Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citatah Tbk. (CTTH) vs Merck Tbk. (MERK) Price & Performance

Citatah Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Citatah Tbk. vs Merck Tbk. — how do they compare? Citatah Tbk. trades at Rp108 (market cap 134.16B, 3.18M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 27.2K 24h volume). The key difference: Merck Tbk. is far larger — about 12.7× Citatah Tbk.'s market cap, and Citatah Tbk. is more actively traded (3.18M versus 27.2K). Which is the better fit depends on your goals.

CTTHMERK
Market Cap
134.16B1.7T
Volume
3.18M27.2K
Lot
31.82K272
Turnover
343.65M104.39M
Average Price
108.013,837.87
Value
343.65M104.39M
Indicative Equilibrium Price
1113,850
Indicative Equilibrium Volume
1441

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CTTH
View details
MERK
View details

About Citatah Tbk.

Citatah was the first private company to develop Indonesia’s marble resources, and has been involved in the extraction and processing of marble for twenty five years. Established in 1974, the company began mining began mining beige marble from its quarry near Bandung, and subsequently achieved a dominant market position for its material in Indonesia. In January 1996, the company acquired a 90% shareholding in PT Quarindah Ekamaju Marmer, a marble company with quarries and a modern processing plant in Singkep, South Sulawesi. Soon after, Citatah acquired a license to mine an additional quarry at Pingkep, which increased the company’s potential raw material output to 60,000 cubic meters a year. In 1998, Citatah opened its Special Projects Centre at Karawang, East of Jakarta. This processing facility comprises a marble and granite slab cutting and polishing factory alongside a design and fabrication factory, which houses a variety of specialist cutting, shaping and finishing machinery. The special projects center is considered to be one of the most modern and complete stone fabrication factories in the world. In 1999, Citatah began excavation at a 50 hectare quarry site in West Timur. This new quarry produces a unique and attractive beige marble which will become the company’s principal export product for the new millennium. Work has already begun on the necessary infrastructure to fully develop the quarry site.  An international sales network of agents and representatives supports Citatah’s production, and a majority owned sales subsidiary, UGMC Inc., in California, USA. In 1999, three quarters of the company’s production was exported, mainly to markets in the Asia Pacific region and the US, an overseas revenues accounted for over 90% of Total Sales, and in 2000, 75% of Total Sales.

Read more on CTTH

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK